Citation Impact
Citing Papers
An Early CD4+ T Cell–dependent Immunoglobulin A Response to Influenza Infection in the Absence of Key Cognate T–B Interactions
2003 Nobel
A Novel Intranasal Virus-Like Particle (VLP) Vaccine Designed to Protect against the Pandemic 1918 Influenza A Virus (H1N1)
2007
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
SARS-CoV and SARS-CoV-2 are transmitted through the air between ferrets over more than one meter distance
2021
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody
2007
Oral adjuvant activity for nasal influenza vaccines caused by combination of two trihydroxy fatty acid stereoisomers from the tuber of Pinellia ternata
2010 StandoutNobel
The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines
2003
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
Innate IL-17-producing cells: the sentinels of the immune system
2010 Standout
Structure and function of the spleen
2005 Standout
Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP]
2012
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Regulation of IgA synthesis at mucosal surfaces
2004 StandoutNobel
Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways
2016
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Nasal drug delivery—possibilities, problems and solutions
2003
FimH Adhesin of Type 1 Fimbriae Is a Potent Inducer of Innate Antimicrobial Responses Which Requires TLR4 and Type 1 Interferon Signalling
2008
Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate
2010
Structure of Dengue Virus
2002 Standout
Chitosan as a novel nasal delivery system for vaccines
2001
Mucosal immunity and vaccines
2005 Standout
Regulation of secondary lymphoid organ development by the nuclear factor‐κB signal transduction pathway
2003
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
2016
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
A universal influenza A vaccine based on the extracellular domain of the M2 protein
1999
Cooperativity Between CD8+ T Cells, Non-Neutralizing Antibodies, and Alveolar Macrophages Is Important for Heterosubtypic Influenza Virus Immunity
2013
Pulmonary Infection with Influenza A Virus Induces Site-Specific Germinal Center and T Follicular Helper Cell Responses
2012
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
Suppression of delayed-type hypersensitivity and IgE antibody responses to ovalbumin by intranasal administration of Escherichia coli heat-labile enterotoxin B subunit-conjugated ovalbumin
1997
Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland
2004 Standout
Enhancement of DNA vaccine potency in rhesus macaques by electroporation
2004
Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection
2012
Age-dependent dysregulation of innate immunity
2013
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
2013 StandoutNature
Priming of CD8+ CTL effector cells in mice by immunization with a stress protein–influenza virus nucleoprotein fusion molecule
1999
NALT- versus PEYER'S-patch-mediated mucosal immunity
2004
Phagocytic antigen processing and effects of microbial products on antigen processing and T‐cell responses
1999
Species differences in the structure and function of the immune system
2003
Evaluation of anti-influenza effects of camostat in mice infected with non-adapted human influenza viruses
1996
Initiation of NALT Organogenesis Is Independent of the IL-7R, LTβR, and NIK Signaling Pathways but Requires the Id2 Gene and CD3−CD4+CD45+ Cells
2002
Safety and Immunogenicity of Intranasally Administered Inactivated Trivalent Virosome‐Formulated Influenza Vaccine ContainingEscherichia coliHeat‐Labile Toxin as a Mucosal Adjuvant
2000
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
2015 Standout
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
Shape effects of filaments versus spherical particles in flow and drug delivery
2007 Standout
A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants
2002
Interactions between commensal intestinal bacteria and the immune system
2004 Standout
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine
2002
Alternative activation of macrophages
2003 Standout
Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes (Iscoms™) and oil-in-water vaccines
1998
The immunobiology of schistosomiasis
2002 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Recombinant Soluble, Multimeric HA and NA Exhibit Distinctive Types of Protection against Pandemic Swine-Origin 2009 A(H1N1) Influenza Virus Infection in Ferrets
2010
Induction of Th2 Responses and IgE Is Largely Due to Carbohydrates Functioning as Adjuvants on Schistosoma mansoni Egg Antigens
1999
Activation of Innate Immunity, Inflammation, and Potentiation of DNA Vaccination through Mammalian Expression of the TLR5 Agonist Flagellin
2005
Enhanced SARS-CoV-2 neutralization by dimeric IgA
2020 StandoutNobel
Regulation and Function of NF-κB Transcription Factors in the Immune System
2009 Standout
DNA Vaccines for Influenza Virus: Differential Effects of Maternal Antibody on Immune Responses to Hemagglutinin and Nucleoprotein
2000
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection
2004 StandoutNobel
Relationship of the quaternary structure of human secretory IgA to neutralization of influenza virus
2015
Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage ofMycobacterium tuberculosisHeat Shock Protein 70 Gene to an Antigen Gene
2001 StandoutNobel
Deficiency of IL-5 receptor alpha-chain selectively influences the development of the common mucosal immune system independent IgA-producing B-1 cell in mucosa-associated tissues.
1999
Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
1996 StandoutNobel
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
2004 StandoutNobel
Biodegradable polymers as biomaterials
2007 Standout
CpG Motifs in Bacterial DNA and Their Immune Effects
2002 Standout
Electroporation as a “Prime/Boost” Strategy for Naked DNA Vaccination against a Tumor Antigen
2005
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
2022 StandoutScienceNobel
Poly-γ-Glutamic Acid Nanoparticles and Aluminum Adjuvant Used as an Adjuvant with a Single Dose of Japanese Encephalitis Virus-Like Particles Provide Effective Protection from Japanese Encephalitis Virus
2011
Lacto-N-fucopentaose III Found on Schitosoma mansoni Egg Antigens Functions as Adjuvant for Proteins by Inducing Th2-Type Response
2001
Of Mice and Not Men: Differences between Mouse and Human Immunology
2004 Standout
Influenza Virus
2001
Increased Frequency of Surface IgA-Positive Plasma Cells in the Intestinal Lamina Propria and Decreased IgA Excretion in Hyper IgA (HIGA) Mice, a Murine Model of IgA Nephropathy with Hyperserum IgA
2000 StandoutNobel
Cytokine Requirements for Induction of Systemic and Mucosal CTL After Nasal Immunization
2001
Growth of Pseudotypes of Vesicular Stomatitis Virus with N-Tropic Murine Leukemia Virus Coats in Cells Resistant to N-Tropic Viruses
1973 StandoutNobel
IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration
2018
Ribonucleic Acud Polymerase in Virions of Newcastle Disease Virus: Comparison with the Vesicular Stomatitis Virus Polymerase
1971 StandoutNobel
CD8 T Cell-Intrinsic GITR Is Required for T Cell Clonal Expansion and Mouse Survival following Severe Influenza Infection
2010 StandoutNobel
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
2003 StandoutNobel
Characterization of human influenza A (H5N1) virus infection in mice: neuro-, pneumo- and adipotropic infection
2000
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
Nasal-Associated Lymphoid Tissue Is a Mucosal Inductive Site for Virus-Specific Humoral and Cellular Immune Responses
2002
Age and testosterone mediate influenza pathogenesis in male mice
2016
Alanine Scanning of the Hepatitis C Virus Core Protein Reveals Numerous Residues Essential for Production of Infectious Virus
2007 StandoutNobel
Deficiency of IL-5 Receptor α-Chain Selectively Influences the Development of the Common Mucosal Immune System Independent IgA-Producing B-1 Cell in Mucosa-Associated Tissues
1999
Simple Sugars to Complex Disease—Mucin-Type O-Glycans in Cancer
2015
ProJuvant™ (Pluronic F127®/chitosan) enhances the immune response to intranasally administered tetanus toxoid
2001
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Airborne transmission of respiratory viruses
2021 StandoutScience
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
1992 Standout
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
2020 Standout
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Works of Hideki Asanuma being referenced
Haplotype networks of SARS-CoV-2 infections in the Diamond Princess cruise ship outbreak
2020
TMPRSS2 Independency for Haemagglutinin Cleavage In Vivo Differentiates Influenza B Virus from Influenza A Virus
2016
Effects of frequent intranasal administration of adjuvant-combined influenza vaccine on the protection against virus infection
1997
A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging
2011
Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine
2001
Superior cross‐protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine
1992
Characterization of mouse nasal lymphocytes isolated by enzymatic extraction with collagenase
1995
Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza
1998
Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection.
1998
Exacerbation of influenzavirus pneumonia by intranasal administration of surfactant in a mouse model
1999
Isolation and characterization of mouse nasal-associated lymphoid tissue
1997
Characterization of neutralizing antibodies in adults after intranasal vaccination with an inactivated influenza vaccine
2011
Cytokine mRNAs in the nasal-associated lymphoid tissue during influenza virus infection and nasal vaccination
2000
Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin)
2000
Effects of intranasal administration of cholera toxin (or Escherichia coli heat-labile enterotoxin) B subunits supplemented with a trace amount of the holotoxin on the brain
2001
Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation
2000
Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs
1999
Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine
2001
Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine
1994
Isotype-specific Selection of High Affinity Memory B Cells in Nasal-associated Lymphoid Tissue
2001
Stable High-Producer Cell Clone Expressing Virus-Like Particles of the Japanese Encephalitis Virus E Protein for a Second-Generation Subunit Vaccine
2003
Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein
1999
Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit
1992
Inhibition of cancer cell growth by anti-Tn monoclonal antibody MLS128.
2009
Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.
1996